Clinical Trials Directory

Trials / Completed

CompletedNCT01034800

The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215

Status
Completed
Phase
Study type
Observational
Enrollment
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The lack of success in treating substance abuse may be contributed to by a limited understanding of the clinical neurobiology of drug abuse. A better understanding of such deficits might aid in the development of more relevant pharmacological and psychosocial treatment approaches. Thus, the purpose of this study is to test the hypothesis that repetitive illicit drug use may be associated with cortical and subcortical structural abnormalities, vascular abnormalities, as well as neuropsychological decrements. Additionally, a battery of psychological tests are administered to provide information about demographics, drug use, neurocognitive measures, and personality structures....

Detailed description

The lack of success in treating substance abuse may be contributed to by a limited understanding of the clinical neurobiology of drug abuse. A better understanding of such deficits might aid in the development of more relevant pharmacological and psychosocial treatment approaches. Thus, the purpose of this study is to test the hypothesis that repetitive illicit drug use may be associated with cortical and subcortical structural abnormalities, vascular abnormalities, as well as neuropsychological decrements. Additionally, a battery of psychological tests are administered to provide information about demographics, drug use, neurocognitive measures, and personality structures.

Conditions

Timeline

Start date
2006-09-01
First posted
2009-12-17
Last updated
2009-12-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01034800. Inclusion in this directory is not an endorsement.